Literature DB >> 31712888

[Current developments in lung transplantation].

C Aigner1.   

Abstract

BACKGROUND: Lung transplantation is the established treatment of benign end-stage pulmonary diseases after failure of alternative surgical and medical treatment options. The aim of this paper is to provide an overview of current developments in selected fields of lung transplantation.
METHODS: A selective literature search was conducted.
RESULTS: Lung transplantation in Germany is currently limited by a donor organ shortage. Measures to increase organ donation rates and to optimize the use of available donor organs are required. Ex-vivo lung perfusion, currently mainly used to re-evaluate marginal donor organs, has the potential to increase the available donor pool and to serve as a platform for additional therapies.
CONCLUSIONS: Refinements in organ allocation, perioperative management, immunosuppression, and in the understanding of acute cellular and humoral rejection as well as chronic lung allograft dysfunction contributed to improvements in long-term outcome after lung transplantation.

Entities:  

Keywords:  Donor selection; Immunosuppressive agents; Perfusion; Presumed consent; Pulmonary function

Mesh:

Year:  2019        PMID: 31712888     DOI: 10.1007/s00292-019-00690-x

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  25 in total

1.  Validation of a post-transplant chronic lung allograft dysfunction classification system.

Authors:  Anke Van Herck; Stijn E Verleden; Annelore Sacreas; Tobias Heigl; Bart M Vanaudenaerde; Lieven J Dupont; Jonas Yserbyt; Eric K Verbeken; Arne P Neyrinck; Dirk Van Raemdonck; Geert M Verleden; Robin Vos
Journal:  J Heart Lung Transplant       Date:  2018-10-04       Impact factor: 10.247

2.  Extended donor criteria for lung transplantation--a clinical reality.

Authors:  Clemens Aigner; Guenther Winkler; Peter Jaksch; Gernot Seebacher; Gyorgy Lang; Sharokh Taghavi; Wilfried Wisser; Walter Klepetko
Journal:  Eur J Cardiothorac Surg       Date:  2005-05       Impact factor: 4.191

3.  Institutional experience with extracorporeal membrane oxygenation in lung transplantation.

Authors:  Clemens Aigner; Wilfried Wisser; Shahrokh Taghavi; György Lang; Peter Jaksch; Damian Czyzewski; Walter Klepetko
Journal:  Eur J Cardiothorac Surg       Date:  2007-01-12       Impact factor: 4.191

4.  Normothermic ex-vivo preservation with the portable Organ Care System Lung device for bilateral lung transplantation (INSPIRE): a randomised, open-label, non-inferiority, phase 3 study.

Authors:  Gregor Warnecke; Dirk Van Raemdonck; Michael A Smith; Gilbert Massard; Jasleen Kukreja; Federico Rea; Gabriel Loor; Fabio De Robertis; Jayan Nagendran; Kumud K Dhital; Francisco Javier Moradiellos Díez; Christoph Knosalla; Christian A Bermudez; Steven Tsui; Kenneth McCurry; I-Wen Wang; Tobias Deuse; Guy Lesèche; Pascal Thomas; Igor Tudorache; Christian Kühn; Murat Avsar; Bettina Wiegmann; Wiebke Sommer; Arne Neyrinck; Marco Schiavon; Fiorella Calabrese; Nichola Santelmo; Anne Olland; Pierre-Emanuel Falcoz; Andre R Simon; Andres Varela; Joren C Madsen; Marshall Hertz; Axel Haverich; Abbas Ardehali
Journal:  Lancet Respir Med       Date:  2018-04-09       Impact factor: 30.700

5.  Normothermic ex vivo lung perfusion in clinical lung transplantation.

Authors:  Marcelo Cypel; Jonathan C Yeung; Mingyao Liu; Masaki Anraku; Fengshi Chen; Wojtek Karolak; Masaaki Sato; Jane Laratta; Sassan Azad; Mindy Madonik; Chung-Wai Chow; Cecilia Chaparro; Michael Hutcheon; Lianne G Singer; Arthur S Slutsky; Kazuhiro Yasufuku; Marc de Perrot; Andrew F Pierre; Thomas K Waddell; Shaf Keshavjee
Journal:  N Engl J Med       Date:  2011-04-14       Impact factor: 91.245

6.  A prospective interventional study on the use of extracorporeal photopheresis in patients with bronchiolitis obliterans syndrome after lung transplantation.

Authors:  Peter Jaksch; Axel Scheed; Maya Keplinger; Mai-Britt Ernst; Theresa Dani; Ulrike Just; Hesam Nahavandi; Walter Klepetko; Robert Knobler
Journal:  J Heart Lung Transplant       Date:  2012-09       Impact factor: 10.247

7.  Outcomes of intraoperative extracorporeal membrane oxygenation versus cardiopulmonary bypass for lung transplantation.

Authors:  Tiago N Machuca; Stephane Collaud; Olaf Mercier; Maureen Cheung; Valerie Cunningham; S Joseph Kim; Sassan Azad; Lianne Singer; Kazuhiro Yasufuku; Marc de Perrot; Andrew Pierre; Karen McRae; Thomas K Waddell; Shaf Keshavjee; Marcelo Cypel
Journal:  J Thorac Cardiovasc Surg       Date:  2014-11-21       Impact factor: 5.209

8.  Lobar lung transplantation--is it comparable with standard lung transplantation?

Authors:  Alexis Slama; Bahil Ghanim; Thomas Klikovits; Axel Scheed; Mir A Hoda; Konrad Hoetzenecker; Peter Jaksch; Jose Matilla; Sharokh Taghavi; Walter Klepetko; Clemens Aigner
Journal:  Transpl Int       Date:  2014-06-17       Impact factor: 3.782

9.  Five-year experience with intraoperative extracorporeal membrane oxygenation in lung transplantation: Indications and midterm results.

Authors:  Fabio Ius; Wiebke Sommer; Igor Tudorache; Murat Avsar; Thierry Siemeni; Jawad Salman; Ulrich Molitoris; Clemens Gras; Bjoern Juettner; Jakob Puntigam; Joerg Optenhoefel; Mark Greer; Nicolaus Schwerk; Jens Gottlieb; Tobias Welte; Marius M Hoeper; Axel Haverich; Christian Kuehn; Gregor Warnecke
Journal:  J Heart Lung Transplant       Date:  2015-09-05       Impact factor: 10.247

Review 10.  Antibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung Transplantation.

Authors:  Deborah J Levine; Allan R Glanville; Christina Aboyoun; John Belperio; Christian Benden; Gerald J Berry; Ramsey Hachem; Don Hayes; Desley Neil; Nancy L Reinsmoen; Laurie D Snyder; Stuart Sweet; Dolly Tyan; Geert Verleden; Glen Westall; Roger D Yusen; Martin Zamora; Adriana Zeevi
Journal:  J Heart Lung Transplant       Date:  2016-02-10       Impact factor: 10.247

View more
  1 in total

1.  Cost drivers in the pharmacological treatment of interstitial lung disease.

Authors:  Phillen Nozibuyiso Maqhuzu; Michael Kreuter; Thomas Bahmer; Nicolas Kahn; Martin Claussen; Rolf Holle; Larissa Schwarzkopf
Journal:  Respir Res       Date:  2021-08-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.